Medication-induced neurotoxicity in critically ill cancer patients

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations


Neurotoxicity associated with cancer treatment and treatment for medical and surgical complications of cancer have been well recognized. Elderly patients, advanced cancer, concomitant polypharmacy, organ failure, and medical comorbidities are all confounders contributing to adverse events related to cancer therapy. Short-term and long-term neurotoxicities may lead to disabilities and poor quality of life in patients with cancer. As a result of early detection of cancer and advances in treatment, cancer survival rates have improved consistently over the last decades and thus longterm survivors may face physical and psychological challenges associated with cancer and cancer treatment. As such, understanding the pathogenic mechanisms, optimizing the strategies for clinical assessment and interventions for the management and prevention of medication-related neurotoxicity is of paramount importance in patient care. This chapter will address the neurotoxicity induced by a number of drug classes commonly used in the treatment of cancer patients.

Original languageEnglish (US)
Title of host publicationOncologic Critical Care
PublisherSpringer International Publishing
Number of pages16
ISBN (Electronic)9783319745886
ISBN (Print)9783319745879
StatePublished - Oct 12 2019


  • Antiepileptic drugs
  • Chemotherapy
  • Immunosuppressive drugs
  • Opiates

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Medication-induced neurotoxicity in critically ill cancer patients'. Together they form a unique fingerprint.

Cite this